# Roles of the Complement System in Peripheral Nerve Injury and Repair

**Authors:** Carmelina Azar, Kaixin Pan, Prini Jain, Elsa Sanchez-Lopez, Sameer B. Shah

PMC · DOI: 10.3390/bioengineering13020251 · Bioengineering · 2026-02-20

## TL;DR

This paper reviews how the complement system influences nerve injury and repair, focusing on acute and chronic injury states.

## Contribution

The paper systematically reviews the role of the complement system in peripheral nerve injury and identifies knowledge gaps.

## Key findings

- Chronic injury is marked by extracellular matrix changes and loss of neurotrophic factors.
- Complement pathways may significantly influence nerve repair and immune responses.
- Systemic effects of nerve injury include impacts on muscles and bones.

## Abstract

When nerves are severed, such as during traumatic injury, an acute injury state is induced, characterized by biological and physical changes in the proximal and distal stumps. Beyond the initial injury phase, over a time frame of weeks to months, nerves that remain unrepaired progressively enter a chronic injury state, characterized by a change in the extracellular matrix structure of the distal stump, the down-regulation of neurotrophic factors and the loss of macrophages’ and Schwann cells’ ability to clear out degraded axons and myelin. There are also potential systemic impacts away from the site of injury, including in end organs such as muscle and bone. The literature suggests that several of these processes may be strongly influenced by innate and adaptive immune system responses, including a major role for complement pathways. This review details evidence in favor of such a possibility, as well as knowledge gaps and areas for future investigation.

## Full-text entities

- **Genes:** Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Tlr7 (toll-like receptor 7) [NCBI Gene 170743], CFH (complement factor H) [NCBI Gene 3075] {aka AHUS1, AMBP1, ARMD4, ARMS1, CFHL3, FH}, Tlr3 (toll-like receptor 3) [NCBI Gene 142980], Serping1 (serine (or cysteine) peptidase inhibitor, clade G, member 1) [NCBI Gene 12258] {aka C1 Inh, C1INH., C1Inh, C1nh}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Ngf (nerve growth factor) [NCBI Gene 18049] {aka Ngfb, beta-NGF}, Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, Cfb (complement factor B) [NCBI Gene 14962] {aka Bf, C2, Fb, H2-Bf}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], Il1 (interleukin 1 complex) [NCBI Gene 111343] {aka Il-1}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Ccl4 (C-C motif chemokine ligand 4) [NCBI Gene 20303] {aka AT744.1, Act-2, MIP-1B, Mip1b, Scya4}, Il17b (interleukin 17B) [NCBI Gene 56069] {aka 1110006O16Rik, 1700006N07Rik, Zcyto7}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Cd59a (CD59a antigen) [NCBI Gene 12509] {aka Cd59, MAC-IP, MACIF}, C5ar2 (complement component 5a receptor 2) [NCBI Gene 319430] {aka C5L2, E030029A11Rik, Gpr77}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, C3 (complement C3) [NCBI Gene 718] {aka AHUS5, ARMD9, ASP, C3a, C3b, CPAMD1}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Il1a (interleukin 1 alpha) [NCBI Gene 16175] {aka Il-1a}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Egf (epidermal growth factor) [NCBI Gene 13645], Cma1 (chymase 1, mast cell) [NCBI Gene 17228] {aka MMCP-5, Mcp-5, Mcp5, Mcpt5}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Cd55 (CD55 molecule, decay accelerating factor for complement) [NCBI Gene 13136] {aka Daf, Daf-GPI, Daf1, GPI-DAF}, Ccl3 (C-C motif chemokine ligand 3) [NCBI Gene 20302] {aka G0S19-1, LD78alpha, MIP-1alpha, MIP1-(a), MIP1-alpha, Mip1a}, Hc (hemolytic complement) [NCBI Gene 15139] {aka C5, C5a, He, Hfib2}, Il13 (interleukin 13) [NCBI Gene 16163] {aka Il-13}, C5ar1 (complement component 5a receptor 1) [NCBI Gene 12273] {aka C5aR, C5r1, Cd88, D7Msu1}, Tlr9 (toll-like receptor 9) [NCBI Gene 81897], Tlr6 (toll-like receptor 6) [NCBI Gene 21899], Tpsab1 (tryptase alpha/beta 1) [NCBI Gene 100503895] {aka MMCP-7, Mcp-7, Mcp7, Mcpt7}, Cr2 (complement receptor 2) [NCBI Gene 12902] {aka C3DR, CD21, CD35, Cr-1, Cr-2, Cr1}, Vcp (valosin containing protein) [NCBI Gene 269523] {aka 3110001E05, CDC48, p97, p97/VCP}, CD46 (CD46 molecule) [NCBI Gene 4179] {aka AHUS2, MCP, MIC10, TLX, TRA2.10}, C3ar1 (complement component 3a receptor 1) [NCBI Gene 12267] {aka AZ3B, C3AR, HNFAG09}, Nlrp1a (NLR family, pyrin domain containing 1A) [NCBI Gene 195046] {aka CARD7, DEFCAP, Gm14, Gm15, NAC, Nalp1}, C1qa (complement component 1, q subcomponent, alpha polypeptide) [NCBI Gene 12259] {aka Adic, C1q}, C4b (complement C4B (Chido blood group)) [NCBI Gene 12268] {aka C4, Ss}, Marcks (myristoylated alanine rich protein kinase C substrate) [NCBI Gene 17118] {aka Macs, PKCSL}, Cxcl15 (C-X-C motif chemokine ligand 15) [NCBI Gene 20309] {aka Il8, Scyb15, lungkine, weche}, CD55 (CD55 molecule (Cromer blood group)) [NCBI Gene 1604] {aka CHAPLE, CR, CROM, DAF, TC}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, C5AR1 (complement C5a receptor 1) [NCBI Gene 728] {aka C5A, C5AR, C5R1, CD88}, F2 (coagulation factor II) [NCBI Gene 14061] {aka Cf-2, Cf2, FII}, Tlr1 (toll-like receptor 1) [NCBI Gene 21897], Csf2 (colony stimulating factor 2 (granulocyte-macrophage)) [NCBI Gene 12981] {aka CSF, Csfgm, GMCSF, Gm-CSf, MGI-IGM}, Tlr2 (toll-like receptor 2) [NCBI Gene 24088] {aka Ly105}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Gdnf (glial cell line derived neurotrophic factor) [NCBI Gene 14573] {aka ATF}
- **Diseases:** fibroplasia (MESH:D012178), hypoxic (MESH:D002534), stroke (MESH:D020521), ischemia (MESH:D007511), neurological deficits (MESH:D009461), nerve (MESH:C537568), SCI (MESH:D013119), SLE (MESH:D008180), Neuromas (MESH:D009463), inflammation (MESH:D007249), injury (MESH:D014947), cerebral damage (MESH:D002539), Peripheral Nerve Injury (MESH:D059348), brain infarction (MESH:D020520), tumor (MESH:D009369), ischemic (MESH:D002545), TBI (MESH:D000070642), neuroinflammation (MESH:D000090862), lung injury (MESH:D055370), chronic kidney disease (MESH:D051436), axonal degeneration (MESH:D009410), MAC (MESH:D015433), neuropathic pain (MESH:D009437), sciatic nerve lesion (MESH:D020426), CNS injury (MESH:D002494), complement dysregulation (OMIM:614878), Wallerian degeneration (MESH:D014855), mechanical allodynia (MESH:D006930), axonal damage (MESH:D001480), chronic (MESH:D002908), angioedema (MESH:D000799), sciatic crush injury (MESH:D000071576), nervous system injury (MESH:D020196), Degenerated myelin (MESH:D003711), Nerve Injury (MESH:D000080902), infection (MESH:D007239), ischemic stroke (MESH:D002544), femoral nerve injury (MESH:D020428)
- **Chemicals:** histamine (MESH:D006632), heparin (MESH:D006493), calcium (MESH:D002118), BioRender (-), FK506 (MESH:D016559), amines (MESH:D000588)
- **Species:** Papio hamadryas (baboon, species) [taxon 9557], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938356/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938356/full.md

## References

136 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938356/full.md

---
Source: https://tomesphere.com/paper/PMC12938356